Comparing efficacy of neoadjuvant therapy of triple-negative breast cancer: A Bayesian network meta-regression analysis
Considering efficacy on pCR and OS/EFS together, ATPtPD1 should be considered as the best recommendation in neoadjuvant therapies of TNBC.
Authors
- Ulf D. Kahlert (ORCID: https://orcid.org/0000-0002-6021-1841)
- Wenjie Shi (ORCID: https://orcid.org/0000-0002-7564-3057)
- Qiang Wang (ORCID: https://orcid.org/0000-0002-6141-0068)
- Jian Liu (ORCID: https://orcid.org/0000-0002-1447-0973)
- Yicheng Jiang (ORCID: https://orcid.org/0000-0002-5869-7256)
- Jiajia Zeng
- Ruijun Tang
- Wenbo Deng
- Meng Xu
Institutions
- Guilin Medical University (CN)
- University Hospital Magdeburg (DE)
- Affiliated Hospital of Guilin Medical College (CN)
- Otto-von-Guericke-Universität Magdeburg (DE)
Publication Details
- Journal
- Medicine
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1097/md.0000000000046962
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00